litlas
ログインアカウント作成

Henrik Schmidt

1981–2026 年に発表

別表記
henrik Schmidt
140
論文数
26,956
被引用数
58
h 指数
123
i10 指数

被引用数

Henrik Schmidt の年別被引用数1984 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 1 件1989 年: 被引用 4 件1990 年: 被引用 1 件1991 年: 被引用 4 件1992 年: 被引用 4 件1993 年: 被引用 14 件1994 年: 被引用 7 件1995 年: 被引用 5 件1996 年: 被引用 14 件1997 年: 被引用 8 件1998 年: 被引用 18 件1999 年: 被引用 11 件2000 年: 被引用 18 件2001 年: 被引用 13 件2002 年: 被引用 14 件2003 年: 被引用 12 件2004 年: 被引用 15 件2005 年: 被引用 16 件2006 年: 被引用 25 件2007 年: 被引用 21 件2008 年: 被引用 17 件2009 年: 被引用 33 件2010 年: 被引用 57 件2011 年: 被引用 59 件2012 年: 被引用 92 件2013 年: 被引用 133 件2014 年: 被引用 115 件2015 年: 被引用 234 件2016 年: 被引用 383 件2017 年: 被引用 454 件2018 年: 被引用 421 件2019 年: 被引用 1,014 件2020 年: 被引用 1,195 件2021 年: 被引用 1,192 件2022 年: 被引用 1,006 件2023 年: 被引用 753 件2024 年: 被引用 1,190 件2025 年: 被引用 642 件2026 年: 被引用 32 件1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,189 件、この内訳の 24.1%中国: 引用元論文 1,548 件、この内訳の 11.7%イギリス: 引用元論文 761 件、この内訳の 5.8%ドイツ: 引用元論文 755 件、この内訳の 5.7%フランス: 引用元論文 716 件、この内訳の 5.4%イタリア: 引用元論文 708 件、この内訳の 5.3%オーストラリア: 引用元論文 524 件、この内訳の 4%オランダ: 引用元論文 456 件、この内訳の 3.4%日本: 引用元論文 440 件、この内訳の 3.3%カナダ: 引用元論文 386 件、この内訳の 2.9%スペイン: 引用元論文 369 件、この内訳の 2.8%スイス: 引用元論文 335 件、この内訳の 2.5%
0%24.1%その他 23.1%

機関

分野

  • Medicine59.2%
  • Biochemistry, Genetics and Molecular Biology11.4%
  • Immunology and Microbiology11%
  • Engineering9.5%
  • Earth and Planetary Sciences3.8%
  • Computer Science2.1%
  • その他3%

トピック

  • Cancer Immunotherapy and Biomarkers17.1%
  • Immunotherapy and Immune Responses8%
  • CAR-T cell therapy research5.9%
  • Immune Cell Function and Interaction3.7%
  • Cutaneous Melanoma Detection and Management3.5%
  • Melanoma and MAPK Pathways3.4%
  • その他58.4%

共著者

全論文

検索で開く
  1. Tertiary lymphoid structures improve immunotherapy and survival in melanoma

    著者: Rita Cabrita, Martin Lauss, Adriana Sanna, Marco Donia, Mathilde Skaarup Larsen, Shamik Mitra, Iva Johansson, Bengt Phung, Katja Harbst, Johan Vallon‐Christersson, Alison van Schoiack, Kristina Lövgren, Sarah Warren, Karin Jirström, Håkan Olsson, Kristian Pietras, Christian Ingvar, Karolin Isaksson, Dirk Schadendorf, Henrik Schmidt, Lars Bastholt, Ana Carneiro, Jennifer A. Wargo, Inge Marie Svane, Göran Jönsson - Nature 2020 被引用: 2,413

  2. Nivolumab in Previously Untreated Melanoma without BRAF Mutation

    著者: Caroline Robert, Georgina V. Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C. Hassel, Piotr Rutkowski, Catriona M. McNeil, Ewa Kalinka‐Warzocha, Kerry J. Savage, Micaela Hernberg, Célèste Lebbé, J. Charles, Catalin Mihalcioiu, Vanna Chiarion‐Sileni, Cornelia Mauch, Francesco Cognetti, Ana Arance, Henrik Schmidt, Dirk Schadendorf, Helen Gogas, L. Lundgren-Eriksson, Christine E. Horak, Brian J. Sharkey, Ian M. Waxman, Victoria Atkinson, Paolo A. Ascierto - New England Journal of Medicine 2014 被引用: 5,352

  3. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock

    著者: Jacob Eifer Møller, Thomas Engstrøm, Lisette Okkels Jensen, Hans Eiskjær, Norman Mangner, Amin Polzin, P. Christian Schulze, Carsten Skurk, Peter Nordbeck, Peter Clemmensen, Vasileios Panoulas, Sebastian Zimmer, Andreas Schäfer, Nikos Werner, Martin Frydland, Lene Holmvang, Jesper Kjærgaard, Rikke Sørensen, Jacob Lønborg, Matias Greve Lindholm, Nanna Louise Junker Udesen, Anders Junker, Henrik Schmidt, Christian Juhl Terkelsen, Steffen Christensen, Evald Høj Christiansen, Axel Linke, Felix Woitek, Ralf Westenfeld, Sven Möbius‐Winkler, Kristian Wachtell, Hanne Berg Ravn, Jens Flensted Lassen, Søren Boesgaard, Oke Gerke, Christian Hassager - New England Journal of Medicine 2024 被引用: 826

  4. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

    著者: Alexander Eggermont, Christian U. Blank, Mario Mandalà, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Anna Maria Di Giacomo, Alfons J.M. van den Eertwegh, Jean‐Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Alexander C. J. van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marréaud, Michal Kiciński, Stefan Suciu, Caroline Robert, Alex Menzies, Thierry Lesimple, Michele Maio, Gerald P. Linette, Michael P. Brown, Peter Hersey, Inge Marie Svane, Laurent Mortier, Jacob Schachter, Catherine Barrow, Ragini R. Kudchadkar, Xinni Song, Caroline Dutriaux, Pietro Quaglino, Friedegund Meier, Paola Queirolo, Daniil Stroyakovskiy, Lars Bastholt, B. Guillot, Claus Garbe, Pablo L. Ortiz‐Romero, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Jean‐Philippe Arnault, Philippe Saïag, Carmen Loquai, Frank Meiß, Jan‐Christoph Simon, Gil Bar‐Sela, Vanna Chiarion‐Sileni, Bernard M. Fitzharris, Mike McCrystal, Phillip Parente, Jean‐François Baurain, P. Combemale, Célèste Lebbé, Axel Hauschild, Naoya Yamazaki, Reinhard Dummer, Mohammed Milhem, Marcin Dzienis, John Walker, L. Geoffrois, M.‐T. Leccia, Lutz Kretschmer, Daniel Hendler, Michal Lotem, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Elaine Dunwoodie, Christoph Höeller, L. Machet, Jessica C. Hassel, Geke A.P. Hospers, Maria-Jose Passos, Max Levin, Martin Fehr, Philippa Corrie, Ashita Waterston, Sigrun Hallmeyer, Henrik Schmidt, V. Descamps, J.‐P. Lacour, Carola Berking, Felix Kiecker, Pier Francesco Ferrucci ほか 32 名 - The Lancet Oncology 2021 被引用: 389

  5. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

    著者: Alexander M.M. Eggermont, Vanna Chiarion‐Sileni, Jean‐Jacques Grob, Reinhard Dummer, Jedd D. Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A. Ascierto, Jon Richards, Célèste Lebbé, Virginia Ferraresi, Michael Smylie, Jeffrey S. Weber, Michele Maio, Lars Bastholt, Laurent Mortier, L. Thomas, Saad Tahir, Axel Hauschild, Jessica C. Hassel, F. Stephen Hodi, Corina Taitt, Veerle de Pril, Gaetan de Schaetzen, Stefan Suciu, Alessandro Testori - New England Journal of Medicine 2016 被引用: 1,313

  6. Phenotyping Cardiogenic Shock

    著者: Elric Zweck, Katherine Thayer, Ole Kristian Lerche Helgestad, Manreet Kanwar, Mohyee Ayouty, A.R. Garan, Jaime Hernández-Montfort, Claudius Mahr, Detlef Wencker, Shashank S. Sinha, Esther Vorovich, Jacob Abraham, William W. O’Neill, Song Li, Gavin Hickey, Jakob Josiassen, Christian Hassager, Lisette Okkels Jensen, Lene Holmvang, Henrik Schmidt, Hanne Berg Ravn, Jacob Eifer Møller, Daniel Burkhoff, Navin K. Kapur - Journal of the American Heart Association 2021 被引用: 251

  7. Computational Ocean Acoustics

    著者: Finn B. Jensen, W. A. Kuperman, Michael B. Porter, Henrik Schmidt - Modern acoustics and signal processing 2011 被引用: 1,589

  8. The wound inflammatory response exacerbates growth of pre‐neoplastic cells and progression to cancer

    著者: Nicole Antonio, Marie Louise Bønnelykke‐Behrndtz, Laura Ward, J. Collin, Ib Jarle Christensen, Torben Steiniche, Henrik Schmidt, Yi Feng, Paul Martin - The EMBO Journal 2015 被引用: 282

  9. Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody

    著者: Neil H. Segal, Theodore F. Logan, F. Stephen Hodi, David F. McDermott, Ignacio Melero, Omid Hamid, Henrik Schmidt, Caroline Robert, Vanna Chiarion‐Sileni, Paolo A. Ascierto, Michele Maio, Walter J. Urba, Tara C. Gangadhar, Satyendra Suryawanshi, Jaclyn Neely, Maria Jure–Kunkel, Suba Krishnan, Holbrook E. Kohrt, Mario Sznol, Ronald Levy - Clinical Cancer Research 2016 被引用: 412

  10. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

    著者: Alexander M.M. Eggermont, Vanna Chiarion‐Sileni, Jean‐Jacques Grob, Reinhard Dummer, Jedd D. Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A. Ascierto, Jon Richards, Célèste Lebbé, Virginia Ferraresi, Michael Smylie, Jeffrey S. Weber, Michele Maio, Cyril Konto, Axel Hoos, Veerle de Pril, Ravichandra Karra Gurunath, Gaetan de Schaetzen, Stefan Suciu, Alessandro Testori - The Lancet Oncology 2015 被引用: 1,255

  11. Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

    著者: Sandra P. D’Angelo, James Larkin, Jeffrey A. Sosman, Célèste Lebbé, Benjamin Brady, Bart Neyns, Henrik Schmidt, Jessica C. Hassel, F. Stephen Hodi, Paul Lorigan, Kerry J. Savage, Wilson H. Miller, Peter Mohr, Iván Márquez‐Rodas, J. Charles, Martin Kaatz, Mario Sznol, Jeffrey S. Weber, Alexander N. Shoushtari, Mary Ruisi, Joel Jiang, Jedd D. Wolchok - Journal of Clinical Oncology 2017 被引用: 643

  12. Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest

    著者: Jesper Kjærgaard, Jacob Eifer Møller, Henrik Schmidt, Johannes Grand, Simon Mølstrøm, Britt Borregaard, Søren Venø, Laura Sarkisian, Dmitry Mamaev, Lisette Okkels Jensen, Benjamin Nyholm, Dan Eik Høfsten, Jakob Josiassen, Jakob Hartvig Thomsen, Jens Jakob Thune, Laust Emil Roelsgaard Obling, Matias Greve Lindholm, Martin Frydland, M Meyer, Matilde Winther‐Jensen, Rasmus Paulin Beske, Ruth Frikke‐Schmidt, Sebastian Wiberg, Søren Boesgaard, Søren Aalbæk Madsen, Vibeke Lind Jørgensen, Christian Hassager - New England Journal of Medicine 2022 被引用: 263

  13. Oxygen Targets in Comatose Survivors of Cardiac Arrest

    著者: Henrik Schmidt, Jesper Kjærgaard, Christian Hassager, Simon Mølstrøm, Johannes Grand, Britt Borregaard, Laust Emil Roelsgaard Obling, Søren Venø, Laura Sarkisian, Dmitry Mamaev, Lisette Okkels Jensen, Benjamin Nyholm, Dan Eik Høfsten, Jakob Josiassen, Jakob Hartvig Thomsen, Jens Jakob Thune, Matias Greve Lindholm, M Meyer, Matilde Winther‐Jensen, Marc Sørensen, Martin Frydland, Rasmus Paulin Beske, Ruth Frikke‐Schmidt, Sebastian Wiberg, Søren Boesgaard, Vibeke Lind Jørgensen, Jacob Eifer Møller - New England Journal of Medicine 2022 被引用: 247

  14. Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

    著者: Caroline Robert, Georgina V. Long, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Laurent Mortier, Piotr Rutkowski, Jessica C. Hassel, Catriona M. McNeil, Ewa Kalinka‐Warzocha, Célèste Lebbé, J. Charles, Micaela Hernberg, Kerry J. Savage, Vanna Chiarion‐Sileni, Catalin Mihalcioiu, Cornelia Mauch, Ana Arance, Francesco Cognetti, Lars Ny, Henrik Schmidt, Dirk Schadendorf, Helen Gogas, Jesús Zoco, Sandra Re, Paolo A. Ascierto, Victoria Atkinson - Journal of Clinical Oncology 2020 被引用: 227

  15. KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

    著者: Pier Francesco Ferrucci, Anna Maria Di Giacomo, Michele Del Vecchio, Victoria Atkinson, Henrik Schmidt, Jacob Schachter, Paola Queirolo, Georgina V. Long, Rosalie Stephens, Inge Marie Svane, Michal Lotem, Mahmoud Abu-Amna, Eduard Gasal, Razi Ghori, Scott J. Diede, Elizabeth Croydon, Antoni Ribas, Paolo A. Ascierto - Journal for ImmunoTherapy of Cancer 2020 被引用: 173

  16. Temporal Trends in Incidence and Patient Characteristics in Cardiogenic Shock Following Acute Myocardial Infarction from 2010 to 2017: A Danish Cohort Study

    著者: Ole Kristian Lerche Helgestad, Jakob Josiassen, Christian Hassager, Lisette Okkels Jensen, Lene Holmvang, Anne Lykke Sørensen, Martin Frydland, Annmarie Touborg Lassen, Nanna Louise Junker Udesen, Henrik Schmidt, Hanne Berg Ravn, Jacob Eifer Møller - European Journal of Heart Failure 2019 被引用: 175

  17. Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

    著者: Paolo A. Ascierto, Pier Francesco Ferrucci, Rosalie Fisher, Michele Del Vecchio, Victoria Atkinson, Henrik Schmidt, Jacob Schachter, Paola Queirolo, Georgina V. Long, Anna Maria Di Giacomo, Inge Marie Svane, Michal Lotem, Gil Bar‐Sela, Félix Couture, Bijoyesh Mookerjee, Razi Ghori, Nageatte Ibrahim, Blanca Homet Moreno, Antoni Ribas - Nature Medicine 2019 被引用: 323

  18. Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

    著者: Alexander M.M. Eggermont, Vanna Chiarion‐Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D. Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A. Ascierto, Jon Richards, Célèste Lebbé, Virginia Ferraresi, Michael Smylie, Jeffrey S. Weber, Michele Maio, Fareeda Hosein, Veerle de Pril, Michal Kiciński, Stefan Suciu, Alessandro Testori - European Journal of Cancer 2019 被引用: 180

  19. An immune-active tumor microenvironment favors clinical response to ipilimumab

    著者: Rui‐Ru Ji, Scott D. Chasalow, Lisu Wang, Omid Hamid, Henrik Schmidt, John Cogswell, Suresh Alaparthy, David M. Berman, Maria Jure–Kunkel, Nathan O. Siemers, Jeffrey R. Jackson, Vafa Shahabi - Cancer Immunology Immunotherapy 2011 被引用: 777

  20. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma

    著者: Trine Øllegaard Jensen, Henrik Schmidt, Holger Jon Møller, Frede Donskov, Morten Høyer, Pia Sjoegren, Ib Jarle Christensen, Torben Steiniche - Cancer 2011 被引用: 280

  21. Duration of Device-Based Fever Prevention after Cardiac Arrest

    著者: Christian Hassager, Henrik Schmidt, Jacob Eifer Møller, Johannes Grand, Simon Mølstrøm, Rasmus Paulin Beske, Søren Boesgaard, Britt Borregaard, Ditte Bekker‐Jensen, Jordi S. Dahl, Martin Frydland, Dan Eik Høfsten, Y Abdi Isse, Jakob Josiassen, Vibeke R. L. Jørgensen, Daniel Kondziella, Matias Greve Lindholm, Emil Moser, Benjamin Nyholm, Laust Emil Roelsgaard Obling, Laura Sarkisian, Frederik T. Søndergaard, Jakob Hartvig Thomsen, Jens Jakob Thune, Søren Venø, Sebastian Wiberg, Matilde Winther‐Jensen, M Meyer, Jesper Kjærgaard - New England Journal of Medicine 2022 被引用: 94

  22. A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

    著者: Omid Hamid, Henrik Schmidt, Aviram Nissan, Laura Ridolfi, Steinar Aamdal, Johan Hansson, Michele Guida, David M. Hyams, Henry Gómez, Lars Bastholt, Scott D. Chasalow, David M. Berman - Journal of Translational Medicine 2011 被引用: 531

  23. Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

    著者: Yanina Jansen, Elisa A. Rozeman, Robert M. Mason, Simone M. Goldinger, Marnix H. Geukes Foppen, Lise Hoejberg, Henrik Schmidt, Johannes V. van Thienen, John B.A.G. Haanen, Leena Tiainen, Inge Marie Svane, Siru Mäkelä, Teofila Seremet, Ana Arance, Reinhard Dummer, Lars Bastholt, Marta Nyakas, Oddbjørn Straume, Alexander M. Menzies, Georgina V. Long, Victoria Atkinson, Christian U. Blank, Bart Neyns - Annals of Oncology 2019 被引用: 228

  24. Rationale and design of DanGer shock: Danish-German cardiogenic shock trial

    著者: Nanna Junker Udesen, Jacob Eifer Møller, Matias Greve Lindholm, Hans Eiskjær, Andreas Schäfer, Nikos Werner, Lene Holmvang, Christian Juhl Terkelsen, Lisette Okkels Jensen, Anders Junker, Henrik Schmidt, Kristian Wachtell, Hölger Thiele, Thomas Engstrøm, Christian Hassager - American Heart Journal 2019 被引用: 203